[144] METLIFE INC SEC Filing

Rhea-AI Filing Summary

MetLife, Inc. (MET) filed a Form 144 reporting a proposed sale of 17 shares of common stock through Bernstein Institutional Services LLC with an aggregate market value of $1,344.19. The filing lists the approximate sale date as 09/19/2025 and shows 665,026,054 shares outstanding. The 17 shares were acquired on 10/11/2021 in a purchase from Citigroup Global Markets with payment completed in cash on 10/13/2021. The filing also discloses prior sales by related MetLife accounts over the past three months totaling 2,628 shares for gross proceeds of $208,112.38. The notice includes the standard representation that the seller knows of no undisclosed material adverse information.

Positive

• Small proposed sale size (17 shares, $1,344.19) is immaterial relative to 665,026,054 shares outstanding
• Acquisition details provided (acquired 10/11/2021 from Citigroup; cash paid 10/13/2021), supporting Form 144 disclosure completeness

Negative

• Multiple recent dispositions in the prior three months totaling 2,628 shares for $208,112.38, indicating ongoing sell activity
• No trading plan date or explicit 10b5-1 instruction is indicated in the filing text provided

Insights

Securities/Equity Analyst

TL;DR: Routine Form 144; proposed sale is immaterial relative to outstanding shares and follows multiple recent plan-related sales.

The filing documents a proposed sale of 17 MetLife shares valued at $1,344.19, which is negligible against the 665 million shares outstanding. The disclosed acquisition date and cash payment indicate these are previously purchased shares, and the broker is Bernstein Institutional Services. The table of recent transactions shows systematic sales from MetLife-related accounts aggregating 2,628 shares and $208,112.38 in gross proceeds over the last three months, consistent with plan-driven or routine disposition activity rather than a single large insider liquidation. Impact on market capitalization or control is immaterial based on amounts disclosed.

Corporate Governance / Compliance Analyst

TL;DR: Filing appears compliant and includes required seller representation; no undisclosed material information is asserted.

The Form 144 includes the acquisition details, broker information, and seller representation about public disclosure of material information, meeting Rule 144 form content requirements. The presence of multiple small sales from retirement and separate accounts suggests transfers consistent with plan or account rebalancing. There is no indication in the filing of a trading plan date or other 10b5-1 instruction, and the signature/remarks section reiterates criminal penalties for misstatement. From a compliance standpoint the submission appears routine and complete for the disclosed transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Bernstein Institutional Services LLC 245 Park Ave New York NY 10167	17	1344.19	665026054	09/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/11/2021	Purchase	Citigroup Global Markets			17	10/13/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	547	43327.87
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	360	28515.6
Separate Account II 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	101	8000.21
Separate Account 149 1 Metlife Way Whippany NJ 07981	Common Stock	06/20/2025	27	2138.67
MetLife 401k Plan Russell 1000 Value 1 Metlife Way Whippany NJ 07981	Common Stock	06/27/2025	1024	82298.88
Separate Account SPI 1 Metlife Way Whippany NJ 07981	Common Stock	07/28/2025	360	27957.6
MetLife 401k Plan Trust-Large Cap Equity Index 1 Metlife Way Whippany NJ 07981	Common Stock	07/31/2025	209	15873.55

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does MetLife's (MET) Form 144 report?

The Form 144 reports a proposed sale of 17 shares of MetLife common stock valued at $1,344.19, to be sold through Bernstein Institutional Services LLC with an approximate sale date of 09/19/2025.

How many MetLife shares are outstanding per the filing?

The filing states there are 665,026,054 shares outstanding.

When and how were the 17 shares acquired according to the filing?

The 17 shares were acquired on 10/11/2021 via a purchase from Citigroup Global Markets with payment in cash on 10/13/2021.

Does the filing show other recent sales by related accounts?

Yes. The filing lists prior sales over the past three months totaling 2,628 shares for gross proceeds of $208,112.38 from various MetLife accounts.

Who is the broker listed for the proposed sale?

The broker named in the Form 144 is Bernstein Institutional Services LLC, 245 Park Ave, New York, NY 10167.